MammoScreen® (4)
Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer. 510(k) K243679, from Therapixel (Nice, FR). Product code QDQ, class 2.
As of Nov 19, 2026, K243679 is an FDA 510(k) held by Therapixel, substantially equivalent on Jul 3, 2025 after 216 days, with no recalls tied to it in FDA's recall database.
- Review time: 216 days
- Recalls: 0
- Cited as a predicate by: 1 device
MammoScreen 4 is a concurrent reading and reporting aid for physicians interpreting screening mammograms. It is intended for use with compatible full-field digital mammography and digital breast tomosynthesis systems.
- MammoScreen® (3)K240301 · Therapixel · Aug 1, 2024
- MammoScreen® (5)K260714 · Therapixel · Jun 26, 2026
- CadAI-B DxK263749 · BeamWorks, Inc. · Nov 6, 2026
- qCT Lung (v1.0)K261517 · Qure.Ai Technologies Pvt. , Ltd. · Sep 14, 2026
- Transpara (2.1.0)K260898 · Screenpoint Medical B.V. · Aug 14, 2026
- CadAI-B DxK260086 · BeamWorks, Inc. · Aug 12, 2026
- See-Mode Augmented Reporting Tool, Breast (SMART-B)K260303 · See-Mode Technologies Pty, Ltd. · Jul 28, 2026
- MammoScreen® (5)K260714 · Therapixel · Jun 26, 2026
- Saige-DxK253825 · DeepHealth, Inc. · Jun 15, 2026
- DeepHealth ProstateAIK253682 · Quantib B.V. · Apr 29, 2026
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 29, 2024
- Review panel
- Radiology
- Regulation
- 21 CFR 892.2090
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files